Literature DB >> 13183059

Aureomycin inactivation by pathogenic bacteria.

S N IYER, A T DUDANI, D L SHRIVASTAVA.   

Abstract

Entities:  

Keywords:  BACTERIA; CHLORTETRACYCLINE

Mesh:

Substances:

Year:  1954        PMID: 13183059     DOI: 10.1007/BF02157389

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  8 in total

1.  Metabolite reversal of antibiotic inhibition, especially reversal of aureomycin inhibition by riboflavin.

Authors:  J W FOSTER; R F PITTILLO
Journal:  J Bacteriol       Date:  1953-10       Impact factor: 3.490

2.  Reversal by complex natural materials of growth inhibition caused by antibiotics.

Authors:  J W FOSTER; R F PITTILLO
Journal:  J Bacteriol       Date:  1953-04       Impact factor: 3.490

3.  Bacterial resistance as a factor in antibiotic therapy.

Authors:  P H LONG
Journal:  Bull N Y Acad Med       Date:  1952-12

4.  THE DETECTION OF PENICILLINASE-PRODUCING PROPERTIES OF MICROORGANISMS.

Authors:  J S Gots
Journal:  Science       Date:  1945-09-21       Impact factor: 47.728

5.  Bacteriological studies of aureomycin.

Authors:  C W PRICE; W A RANDALL; H WELCH
Journal:  Ann N Y Acad Sci       Date:  1948-11-30       Impact factor: 5.691

6.  Laboratory studies with aureomycin.

Authors:  T F PAINE; H S COLLINS; M FINLAND
Journal:  Ann N Y Acad Sci       Date:  1948-11-30       Impact factor: 5.691

7.  Crossresistance to antibiotics; effect of repeated exposure of bacteria to aureomycin, terramycin, chloramphenicol or neomycin on the resistance to all of these antibiotics and to streptomycin and penicillin.

Authors:  T M GOCKE; M FINLAND
Journal:  J Lab Clin Med       Date:  1951-11

8.  Comparison of in vitro sensitivity of freshly isolated pathogenic bacteria to terramycin and other antibiotics.

Authors:  J C RANSMEIER; H E BROWN; N DAVIS
Journal:  J Lab Clin Med       Date:  1951-10
  8 in total
  1 in total

1.  Microbiological degradation of tetracyclines.

Authors:  E MEYERS; D A SMITH
Journal:  J Bacteriol       Date:  1962-10       Impact factor: 3.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.